2024-08-28

Eli Lilly releases new, cheaper form of weight loss drug

Eli Lilly on Tuesday released a new form of its weight loss drug Zepbound for roughly half its usual monthly list price to reach millions of patients without insurance coverage for the popular injection, such as those with Medicare.  The move also aims to expand the supply of Zepbound in the U.S. as demand skyrockets, and to ensure eligible…

Read More

2024-08-19

Why Walgreens, CVS retail pharmacies are struggling

The abundance of Walgreens and CVS Health stores makes them convenient for whenever Shriya Raghavan, a research associate based in Philadelphia, needs to pick up necessities like gum, deodorant and soap.  But she said she often has to wait for employees to unlock cabinets or stand in lengthy lines to pick up prescriptions as pharmacists juggle tasks. Those are…

Read More

2024-08-09

Eli Lilly (LLY) earnings Q2 2024

Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by $3 billion as sales of its blockbuster diabetes drug Mounjaro and weight loss injection Zepbound spike. Shares of Eli Lilly closed more than 9% higher on Thursday. The drugmaker now expects revenue for the year to come in between…

Read More